{{Rsnum
|rsid=963549
|Gene=OPRK1
|Chromosome=8
|position=53229264
|Orientation=plus
|GMAF=0.2328
|Gene_s=OPRK1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 72.3 | 25.9 | 1.8
| HCB | 82.5 | 16.8 | 0.7
| JPT | 88.5 | 10.6 | 0.9
| YRI | 16.3 | 47.6 | 36.1
| ASW | 29.8 | 42.1 | 28.1
| CHB | 82.5 | 16.8 | 0.7
| CHD | 90.8 | 9.2 | 0.0
| GIH | 86.1 | 13.9 | 0.0
| LWK | 21.8 | 55.5 | 22.7
| MEX | 59.6 | 36.8 | 3.5
| MKK | 37.8 | 51.9 | 10.3
| TSI | 77.5 | 21.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22138325
|Title=Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}